Anticorps Recombinant de lapin anti-CD49b

CD49b Recombinant Antibody for FC

Hôte / Isotype

Mouse / IgG2a

Réactivité testée

Humain

Applications

FC

Conjugaison

Non conjugué

CloneNo.

AK7

N° de cat : 65583-1-MR

Synonymes

ITGA2, AK7, BR, Collagen receptor, GPIa



Applications testées

Résultats positifs en cytométrieplaquettes de sang périphérique humain,

Dilution recommandée

ApplicationDilution
This reagent has been tested for flow cytometric analysis. It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, check data in validation data gallery

Informations sur le produit

65583-1-MR cible CD49b dans les applications de FC et montre une réactivité avec des échantillons Humain

Réactivité Humain
Hôte / Isotype Mouse / IgG2a
Clonalité Recombinant
Type Anticorps
Immunogène Plaquettes humaines
Nom complet integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)
Masse moléculaire calculée 126 kDa
Numéro d’acquisition GenBankNM_002203
Symbole du gène Integrin alpha 2
Identification du gène (NCBI) 3673
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Purification par protéine A
Tampon de stockage PBS with 0.09% sodium azide
Conditions de stockageStore at 2-8°C. Stable for one year after shipment.

Informations générales

CD49b, also known as alpha2 integrin, is a type I transmembrane glycoprotein which forms an adhesion molecule VLA-2 with beta1 integrin. CD49b is a receptor for many (extracellular) matrix and non-matrix molecules (PMID: 23847623). CD49b is expressed on numerous cell types including platelets, activated T cells, B cells, and monocytes. CD49b activation skews NK cell effector function to a phenotype that exhibits elevated IFN-γ production with a concomitant inhibition of motility and cytolytic function (PMID: 32971468, 32762681). The Anti-Human CD49b antibody, clone AK7, is derived from Human platelets.

Protocole

Product Specific Protocols
FC protocol for CD49b antibody 65583-1-MRDownload protocol
Standard Protocols
Click here to view our Standard Protocols
{{ptg:RelatedPrimaryAntibodies}}